Loading clinical trials...
Loading clinical trials...
Treatment Pattern, Clinical Outcome and Healthcare Resource Utilization Associated With Chinese Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Retrospective Observational Study
Conditions
Interventions
Non-Interventional
Locations
1
China
Local Institution
Tianjin, Tianjin Municipality, China
Start Date
November 30, 2017
Primary Completion Date
June 7, 2019
Completion Date
September 28, 2019
Last Updated
June 27, 2022
NCT06514534
NCT05143840
NCT06994676
NCT05453500
NCT06523556
NCT06236724
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions